Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study(TOPS-CSVD)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1052 participants.
Also called NCT06061692
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,052 participants
- Sponsor
- Registry
-
NCT06061692
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06061692. Randomized; quadruple masking; primary purpose treatment. Start 2023-10 (anticipated); primary completion 2026-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study(TOPS-CSVD)
- Condition
- Cerebral Small Vessel Diseases
- Intervention (Drug)
- Tongxinluo Capsule
- Lead sponsor
- Fudan University
Record details
- Record id
cardio:ct-nct06061692- Content hash
4c5b47af548cdc9efb1e0f08b54afb7138f199ede906a70b9841535a5c2f9861